Keyphrases
4-cycle
16%
Advanced Stage
33%
Anemia
16%
Anthracyclines
100%
Breast Cancer
33%
Breast Cancer Recurrence
100%
Confidence Interval
16%
Duration of Response
16%
Eastern Cooperative Oncology Group Performance Status (ECOG PS)
16%
Folic Acid
16%
Heavily Pretreated Patients
16%
Intravenous Infusion
16%
Leukopenia
16%
Locally Advanced Breast Cancer
100%
Lymphopenia
16%
Median Progression-free Survival
16%
Median Survival
16%
Metastatic Breast Cancer
16%
Neutropenia
16%
Overall Response Rate
16%
Patients with Breast Cancer
16%
Pemetrexed
100%
Phase II Study
100%
Pretreated Patients
16%
Previously Treated
16%
Progressive Disease
16%
Protocol Amendments
16%
Relapsed Disease
16%
Salvage Treatment
16%
Taxanes
100%
Treatment Phase
100%
Vitamin B12
16%
Vitamin Supplementation
50%
Medicine and Dentistry
Anemia
16%
Anthracycline
100%
Breast Cancer
100%
Diseases
16%
Folic Acid
16%
Intravenous Drug Administration
16%
Leukopenia
16%
Lymphocytopenia
16%
Metastatic Breast Cancer
100%
Neutropenia
16%
Oncology
16%
Pemetrexed
100%
Progression Free Survival
16%
Supplementation
16%
Vitamin B12
16%
Vitamin Supplementation
50%
Pharmacology, Toxicology and Pharmaceutical Science
Anemia
16%
Anthracycline
100%
Breast Cancer
100%
Diseases
16%
Folic Acid
16%
Leukopenia
16%
Lymphocytopenia
16%
Metastatic Breast Cancer
100%
Neutropenia
16%
Pemetrexed
100%
Progression Free Survival
16%
Taxane
100%
Vitamin B12
16%